<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:03:11Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5129924" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5129924</identifier><datestamp>2016-12-11</datestamp><setSpec>oncotarget</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Oncotarget</journal-id>
      <journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id>
      <journal-id journal-id-type="publisher-id">Oncotarget</journal-id>
      <journal-id journal-id-type="publisher-id">ImpactJ</journal-id>
      <journal-title-group>
        <journal-title>Oncotarget</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1949-2553</issn>
      <publisher>
        <publisher-name>Impact Journals LLC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5129924</article-id>
      <article-id pub-id-type="pmcid">PMC5129924</article-id>
      <article-id pub-id-type="pmc-uid">5129924</article-id>
      <article-id pub-id-type="pmid">27172900</article-id>
      <article-id pub-id-type="pmid">27172900</article-id>
      <article-id pub-id-type="publisher-id">9258</article-id>
      <article-id pub-id-type="doi">10.18632/oncotarget.9258</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Paper: Pathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>PRRT2</italic> mutations lead to neuronal dysfunction and neurodevelopmental defects</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Yo-Tsen</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nian</surname>
            <given-names>Fang-Shin</given-names>
          </name>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="A4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>Wan-Ju</given-names>
          </name>
          <xref ref-type="aff" rid="A4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tai</surname>
            <given-names>Chin-Yin</given-names>
          </name>
          <xref ref-type="aff" rid="A5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kwan</surname>
            <given-names>Shang-Yeong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Chien</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuo</surname>
            <given-names>Pei-Wen</given-names>
          </name>
          <xref ref-type="aff" rid="A4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Po-Hsi</given-names>
          </name>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Chin-Yi</given-names>
          </name>
          <xref ref-type="aff" rid="A6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Chia-Wei</given-names>
          </name>
          <xref ref-type="aff" rid="A4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Yi-Chung</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Soong</surname>
            <given-names>Bing-Wen</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>Jin-Wu</given-names>
          </name>
          <xref ref-type="aff" rid="A4">
            <sup>4</sup>
          </xref>
          <xref ref-type="aff" rid="A7">
            <sup>7</sup>
          </xref>
          <xref ref-type="aff" rid="A8">
            <sup>8</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><sup>1</sup> Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan</aff>
      <aff id="A2"><sup>2</sup> Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan</aff>
      <aff id="A3"><sup>3</sup> Program in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan</aff>
      <aff id="A4"><sup>4</sup> Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan</aff>
      <aff id="A5"><sup>5</sup> Istitute of Pharmaceutics, Development Center for Biotechnology, New Taipei City, Taiwan</aff>
      <aff id="A6"><sup>6</sup> Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan</aff>
      <aff id="A7"><sup>7</sup> Brain Research Center, National Yang-Ming University, Taipei, Taiwan</aff>
      <aff id="A8"><sup>8</sup> Biophotonics and Molecular Imaging Research Center, National Yang-Ming University, Taipei, Taiwan</aff>
      <author-notes>
        <corresp id="cor1">
          <bold>
            <italic>Correspondence to:</italic>
          </bold>
          <italic>Jin-Wu Tsai,</italic>
          <email>tsaijw@ym.edu.tw</email>
        </corresp>
        <corresp id="cor2">
          <italic>Bing-Wen Soong,</italic>
          <email>bwsoong@ym.edu.tw</email>
        </corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <day>28</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <volume>7</volume>
      <issue>26</issue>
      <fpage>39184</fpage>
      <lpage>39196</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>2</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>4</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: Â© 2016 Liu et al.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Mutations in the proline-rich transmembrane protein 2 (<italic>PRRT2</italic>) gene cause a wide spectrum of neurological diseases, ranging from paroxysmal kinesigenic dyskinesia (PKD) to mental retardation and epilepsy. Previously, seven PKD-related <italic>PRRT2</italic> heterozygous mutations were identified in the Taiwanese population: P91QfsX, E199X, S202HfsX, R217PfsX, R217EfsX, R240X and R308C. This study aimed to investigate the disease-causing mechanisms of these <italic>PRRT2</italic> mutations. We first documented that Prrt2 was localized at the pre- and post-synaptic membranes with a close spatial association with SNAP25 by synaptic membrane fractionation and immunostaining of the rat neurons. Our results then revealed that the six truncating Prrt2 mutants were accumulated in the cytoplasm and thus failed to target to the cell membrane; the R308C missense mutant had significantly reduced protein expression, suggesting loss-of function effects generated by these mutations. Using <italic>in utero</italic> electroporation of shRNA into cortical neurons, we further found that knocking down Prrt2 expression <italic>in vivo</italic> resulted in a delay in neuronal migration during embryonic development and a marked decrease in synaptic density after birth. These pathologic effects and novel disease-causing mechanisms may contribute to the severe clinical symptoms in <italic>PRRT2</italic>ârelated diseases.</p>
      </abstract>
      <kwd-group>
        <kwd>PRRT2</kwd>
        <kwd>neuronal migration</kwd>
        <kwd>synaptic development</kwd>
        <kwd>paroxysmal kinesigenic dyskinesia (PKD)</kwd>
        <kwd>Taiwan</kwd>
        <kwd>Pathology Section</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>INTRODUCTION</title>
      <p>Mutations in the proline-rich transmembrane protein 2 gene (<italic>PRRT2</italic>, NM_145239.2) have been identified to be the causes of many neurological diseases. Heterozygous <italic>PRRT2</italic> mutations cause paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), infantile convulsions and choreoathetosis (ICCA), hemiplegic migraine (HM), episodic ataxia (EA), paroxysmal torticollis, or a combination of them [<xref rid="R1" ref-type="bibr">1</xref>â<xref rid="R14" ref-type="bibr">14</xref>]. Although rarely identified, patients with biallelic or homozygous <italic>PRRT2</italic> mutations presented complex forms of PKD in combination with intellectual disability or cerebellar atrophy [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. Previously, our group identified seven different PKD-related <italic>PRRT2</italic> mutations in the Taiwanese population: p.P91Qfs*24 (P91QfsX), p.E199X (E199X), p.S202Hfs*16 (S202HfsX), p.R217Pfs*8 (R217PfsX), p.R217Efs*12 (R217EfsX), p.R240X (R240X) and p.R308C (R308C) [<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R17" ref-type="bibr">17</xref>]. Six of these mutations result in premature truncation before the first predicted transmembrane domain. The only missense mutation, R308C, is located in the predicted cytoplasmic domain (Figure <xref ref-type="fig" rid="F1">1</xref>). There were a few <italic>in vitro</italic> studies suggesting that PRRT2 may interact with SNAP25 (the synaptosomal-associated protein, 25kD), a critical molecule in neurotransmitter release [<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>]. However, it is still not fully understood how mutated PRRT2 causes pathological effects on the nervous system <italic>in vivo</italic>.</p>
      <fig id="F1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <title>Genomic organization of the human PRRT2 gene and the distribution of the PRRT2 mutations identified in Taiwanese PKD patients</title>
          <p>The genomic organization of human <italic>PRRT2</italic> gene and the distribution of the seven <italic>PRRT2</italic> mutations identified in Taiwanese PKD patients are illustrated in the upper panel. The predicted domains of the PRRT2 protein are shown in the lower panel. Six of the <italic>PRRT2</italic> truncating mutations are localized in the predicted extracellular domain (amino acids 1-268), and five are clustered within or around the proline-rich domain (the red region).</p>
        </caption>
        <graphic xlink:href="oncotarget-07-39184-g001"/>
      </fig>
      <p>Here, we generated a polyclonal antibody against Prrt2 which helped document that Prrt2 was localized at both the pre- and post-synaptic membranes with a close spatial association with SNAP25. We then revealed that abnormal intracellular trafficking and decreased expression of the aforementioned seven <italic>PRRT2</italic> mutations could lead to its functional loss. Furthermore, by <italic>in utero</italic> electroporation of Prrt2 shRNA into mouse embryos, we showed that Prrt2 knockdown in cortical neurons caused a delay in neuronal migration and defects in synaptic development. These pathological effects may contribute to the severe clinical syndromes in patients with homozygous or biallelic <italic>PRRT2</italic> mutations.</p>
    </sec>
    <sec id="s2">
      <title>RESULTS</title>
      <sec id="s2_1">
        <title>Production of a highly specific Prrt2 polyclonal antibody</title>
        <p>To detect endogenous Prrt2, we first generated a polyclonal antibody against the extracellular domain of the Prrt2 protein and tested its specificity in rat and mouse brain lysates, as well as in COS-7 cells transfected with EGFP-Prrt2 construct (Figure <xref ref-type="fig" rid="F2">2A</xref>). The antibody showed high specificity for Prrt2, revealing a single major band (~ 65 kD) with few minor bands in each system using Western blotting. By using the antibody, endogenous Prrt2 was shown to localize at the cell membrane of mouse cortical neurons cultured for 3 or 16 days <italic>in vitro</italic> (DIV) (Figure <xref ref-type="fig" rid="F2">2B</xref>, left and middle panels). We also examined the distribution of EGFP-Prrt2 in transfected cultured HEK293T cells (Figure <xref ref-type="fig" rid="F2">2B</xref>, right panel). The fluorescence signals from EGFP and Prrt2 antibody predominantly co-localized at the cell membrane, consistent with previous observations using other protein tags [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R20" ref-type="bibr">20</xref>]. To further test the specificity of the antibody, we test whether knocking down Prrt2 expression in cells by RNA interference (RNAi) will eliminate antibody reactivity (Figure <xref ref-type="fig" rid="F2">2C</xref>). Two short hairpin RNA (shRNA) plasmids targeting different Prrt2 mRNA regions were used and showed 65% (shPrrt2 #1) and 98% (shPrrt2 #2) knockdown efficiencies 48 hours after transfection. We then transfected these shRNA constructs to cultured cortical neurons and found that Prrt2 signal was significantly lower than that in the surrounding non-transfected cells, indicating that the polyclonal antibody is highly specific.</p>
        <fig id="F2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <title>Prrt2 protein recognized by a specific polyclonal antibody</title>
            <p><bold>A.</bold> A polyclonal antibody against amino acids 1-268 of the bacterially-expressed Prrt2 protein (I) was generated. Prrt2 protein from adult rat brain lysates was detected using the first bleed of Prrt2 anti-serum obtained from a rabbit (II, right lane). Preimmune serum drawn from the rabbit before antigen injection was the control (II, left lane). The antibody also recognized Prrt2 in mouse brain lysates and EGFP-tagged Prrt2 transfected into COS7 cells (III). <bold>B.</bold> Subcellular localization of Prrt2 protein by immunoflourescence staining with the polyclonal antibody. Endogenous Prrt2 protein (green) localized predominantly to cell membranes in cultured cortical neurons 3 and 16 days <italic>in vitro</italic> (DIV) (left panel). The distribution of EGFP-tagged Prrt2 also localized to the cell membrane in HEK293T cells transfected with EGFP-Prrt2, as revealed by the EGFP signal (green) and Prrt2 immuostaining (red). The distribution of Prrt2 based on EGFP signal and antibody staining was highly concordant and resembled the pattern of endogenous Prrt2 in cultured neurons. All cells were counterstained with DAPI staining (blue) to show the nuclei. Scale bar = 10 Î¼m. <bold>C.</bold> Prrt2 protein level revealed by immunostaining with polyclonal antibody in cultured neurons transfected with Prrt2 shRNA. Upper panel: Prrt2 expression was knocked down by cotransfecting short hairpin RNA (shRNA) with Prrt2 into cultured cells. Two shRNA plasmids targeting different Prrt2 mRNA regions showed 65% (shPrrt2 #1) and 98% (shPrrt2 #2) knockdown efficiency 48 hours after transfection. Lower panel: Immunostaining in cultured neurons shows that endogenous Prrt2 signal (red) was significantly reduced in shPrrt2-transfected neurons (green, arrows) compared with the surrounding untransfected cells. All cells were counterstained with DAPI staining (blue) to show the nuclei. Scale bar = 10 Î¼m.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-39184-g002"/>
        </fig>
      </sec>
      <sec id="s2_2">
        <title>Close co-localization of Prrt2 and SNAP25 on the pre- and post-synaptic membranes</title>
        <p>Synaptic membrane fractionation and postsynaptic density (PSD) preparation from adult rat brain lysates were carried out with several pre- and post-synaptic markers to confirm if Prrt2 is present on synapses (Figure <xref ref-type="fig" rid="F3">3A</xref>). Prrt2 was enriched in the synaptic membrane fraction (LP1), but was also detected in synaptic vesicle (LP2) and postsynaptic density (PSDI) fractions, indicating the presence of Prrt2 at both pre- and post-synaptic membranes. To further characterize the subcellular localization of Prrt2, we visualized the protein along dendritic spines in mature cultured hippocampal neurons of adult rats. Prrt2 was visible at the tips of these spines where the majority of excitatory synapses are formed [<xref rid="R21" ref-type="bibr">21</xref>, <xref rid="R22" ref-type="bibr">22</xref>], with a close spatial association with SNAP25 (Figure <xref ref-type="fig" rid="F3">3B</xref>).</p>
        <fig id="F3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <title>Localization of Prrt2 at the pre- and post-synaptic membranes</title>
            <p><bold>A.</bold> Membrane fractionation assay and post-synaptic density (PSD) preparation of the protein from an adult rat brain. Prrt2 and SNAP25 were present and co-fractionated in both pre- and post-synaptic compartments. PSD95 and GluA1 are PSD proteins that were enriched in PSD fractions. Synaptotagmin I (Sygt1)-a presynaptic vesicle protein was present in the LP2 fraction, but absent from all PSD fractions. PSD95, GluA2 and N-cadherin are post-synaptic membrane proteins that were absent from the LP2 fraction. H = homogenate, S1 = low-speed supernatant, P1 = nuclear pellet and debris, S2 = cytosol plus light membrane, P2 = crude synaptosomal fraction, S3 = cytosol, P3 = light membranes, LS1 = synaptosomal cytosolic fraction, LP1 = synaptosomal membrane fraction, LS2 = luminal fraction of synaptic vesicles, LP2 = synaptic vesicle membrane fraction. PSDI, II and III represent the detergent extractability of PSD resident proteins. PSD1 represents Single Triton X-100 extraction. PSDII and PSDIII were obtained in the second round of Triton extraction and Sarkosyl extraction of PSDI, respectively. <bold>B.</bold> Immunostaining of Prrt2 and SNAP25 in GFP-expressing cultured hippocampal neurons (DIV 17). A dendritic segment with multiple spines (specialized protrusive structures) is shown in the large image. The amplified images highlight the localization of Prrt2 (red) and SNAP25 (blue), which co-localized at the tip of a spine (orange arrow) where a synapse was forming.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-39184-g003"/>
        </fig>
      </sec>
      <sec id="s2_3">
        <title>Failure of membrane targeting in truncated Prrt2 mutants</title>
        <p>The subcellular localization of the seven PKD-related mutant Prrt2 was then explored in cultured cells (Figure <xref ref-type="fig" rid="F4">4</xref>). HEK293T cells were transfected with EGFP-Prrt2 or its mutants and imaged with confocal microscopy. Wild type (WT) Prrt2 protein predominantly localized to the plasma membrane, consistent with the pattern observed for endogenous Prrt2 in cultured mouse neurons. In contrast, the six truncated Prrt2 mutants were mostly retained in the cytoplasm, with some mutant proteins (P91QfsX, E199X and R240X) found in the nucleus, indicating abnormal intracellular trafficking of the mutant proteins. Of note, the R308C mutant was expressed on the plasma membrane in a pattern indistinguishable from WT-Prrt2.</p>
        <fig id="F4" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <title>Subcellular localization of PKD-related PRRT2 mutations in cultured HEK293T cells</title>
            <p>The six prematurely truncating Prrt2 mutants (P91QfsX, E199X, S202HfsX, R217EfsX, E217PfsX and R240X) were retained in the cytoplasm and failed to be properly transported to the membrane. Some faint signal from the p.P91QfsX, p.E199X and p.S202HfsX Prrt2 mutant proteins could be found in the nucleus. The missense R308C mutant protein had a membrane localization similar to the pattern for WT-Prrt2. Scale bar = 10 Î¼m.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-39184-g004"/>
        </fig>
      </sec>
      <sec id="s2_4">
        <title>Reduced Prrt2 protein level caused by the R308C mutation</title>
        <p>Although the R308C mutant was found to localize at the plasma membrane as WT, it is possible that insufficient level of mutant protein causes dysfunction of PRRT2. To address this possibility, EGFP- and HA-tagged WT-Prrt2 and the R308C mutant were transiently transfected to HEK293T cells and Prrt2 expression levels were examined by Western blotting. Significantly reduced protein levels were observed for the R308C mutant compared to WT-Prrt2 (Figure <xref ref-type="fig" rid="F5">5</xref>), suggesting that this missense mutation may cause disease through reduced expression rather than abnormal trafficking.</p>
        <fig id="F5" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <title>Reduced expression level of the R308C PRRT2 mutant</title>
            <p><bold>A.</bold> GFP- and HA-tagged WT-Prrt2 and the R308C mutant were transiently transfected into the HEK293T cell line. Prrt2 expression levels were determined using Western blotting and were normalized to that of WT-Prrt2. GAPDH was used as an internal control. <bold>B.</bold> A significant reduction of Prrt2 levels was observed for the R308C mutant (*: <italic>p</italic> &lt; 0.05, **: <italic>p</italic> &lt; 0.01). Error bars indicate SEM. Statistics were performed by a two-tailed, unpaired Student's t-test.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-39184-g005"/>
        </fig>
      </sec>
      <sec id="s2_5">
        <title>Delayed neuronal migration during development caused by Prrt2 knockdown</title>
        <p>To explore the loss-of-function effects of Prrt2 in the brain, we transfected Prrt2 shRNA constructs with cDNA expressing EGFP into mouse brains by <italic>in utero</italic> electroporation at embryonic (E) day 14.5 [<xref rid="R23" ref-type="bibr">23</xref>, <xref rid="R24" ref-type="bibr">24</xref>]. Using this method, plasmids can be introduced into a subset of neural stem cells (<italic>i.e.</italic> radial glia) during cortical development. The development of electroporated mouse brains was examined 3 and 5 days post electroporation, at E17.5 and postnatal (P) day 1, respectively. Normally, neurons generated from neural stem cells in the ventricular zone (VZ) migrate along radial fibers towards the cortical plate (CP) [<xref rid="R25" ref-type="bibr">25</xref>â<xref rid="R27" ref-type="bibr">27</xref>]. The neurons in the brains electroporated with Prrt2 shRNA exhibited a delay in neuronal migration from the VZ to the CP, with many cells accumulated at the VZ, subventricular zone (SVZ) and intermediate zone (IZ) (Figure <xref ref-type="fig" rid="F6">6A</xref>, top panels). Quantification of the cells at day 3 (E17.5) revealed significantly reduced numbers of neurons in the CP, as most of the cells remained in the VZ (Figure <xref ref-type="fig" rid="F6">6B</xref>). This migration delay was partially rescued by expressing Prrt2 in knockdown cells. Later, at day 5 (P1), most of the neurons in both the control and shRNA-electroporated brains reached the CP (Figure <xref ref-type="fig" rid="F6">6A</xref>, bottom panels), indicating that neuronal migration was delayed rather than completely blocked during cortical development.</p>
        <fig id="F6" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <title>Delay in neuronal migration by Prrt2 knockdown during development</title>
            <p><bold>A.</bold> Coronal sections of the mouse brains 3 and 5 days after <italic>in utero</italic> electroporation of shControl or shPrrt2 constructs at E14.5. Three days after electroporation, cells expressing EGFP (green) and shControl had started migration, with many cells having already reached the CP. More cells were restricted to the VZ and IZ in the brains electroporated with each of the shPrrt2. This migration delay was rescued by co-transfection of shPrrt2 and Prrt2 constructs (upper panel). When brain sections were examined 5 days post electroporation, most cells in both shControl and shPrrt2 groups had reached the CP (lower panel). All sections were stained with DAPI (blue) to show the cell nuclei. Scale bars = 100 Î¼m. <bold>B.</bold> Statistical analysis showed significant differences in cell distribution in the CP, IZ and VZ at E17.5for the four conditions. Error bars represent SEM; *: <italic>p</italic> &lt; 0.05, ** : <italic>p</italic> &lt; 0.01.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-39184-g006"/>
        </fig>
      </sec>
      <sec id="s2_6">
        <title>Decreased dendritic spine density caused by Prrt2 knockdown</title>
        <p>Since we documented the presence of Prrt2 at both the pre- and post-synaptic membranes, we hypothesized that loss of normal PRRT2 functions may cause changes in synaptic connections, which could be visualized by the density of dendritic spines [<xref rid="R28" ref-type="bibr">28</xref>]. Therefore, we investigated changes in dendritic spines in Prrt2 knockdown mice. Plasmids expressing Prrt2 shRNA and EGFP were electroporated into the developing cortex of mouse embryos <italic>in utero</italic> at E14.5. The mice were allowed to give birth and the brains of their pups were examined at P14, P21 and P30. Pyramidal neurons of layer 2/3 (L2/3) were observed under a confocal or two-photon microscope. We counted the numbers of dendritic spines along apical dendrites (Figure <xref ref-type="fig" rid="F7">7A</xref>) [<xref rid="R29" ref-type="bibr">29</xref>]. At P14, neurons expressing Prrt2 shRNA showed a dendritic spine density similar to neurons in the control brains. However, there were significant decreases in spine density for neurons expressing shPrrt2 #2 at P21 and P30 (Figure <xref ref-type="fig" rid="F7">7B</xref>). The reduction of dendritic spine density was not observed in the neurons expression shPrrt2 #1 (data not shown). As shPrrt2 #2 exhibited a much higher knockdown efficiency than shPrrt2 #1 (Figure <xref ref-type="fig" rid="F2">2C</xref>), our results suggested that nearly complete knockdown of Prrt2 may be required for the defect in dendritic spine during neural development and the loss-of-functional effect may be dose-dependent.</p>
        <fig id="F7" orientation="portrait" position="float">
          <label>Figure 7</label>
          <caption>
            <title>Decreased dendritic spine density after Prrt2 knockdown</title>
            <p><bold>A.</bold> Dendritic spines were imaged at P21 and P30 in brains electroporated <italic>in utero</italic> with control or Prrt2 shRNA along with EGFP constructs at E14.5. Lower spine densities for Prrt2 shRNA-expressing pyramidal neurons were observed on representative dendrites at both P21 and P30. <bold>B.</bold> Statistical analysis of spine density of dendrites at P14, P21 and P30. There was no significant difference between control and Prrt2 shRNA-expressing groups at P14. Significant decreases in spine density for Prrt2 shRNA-expressing cells were observed at P21 and P30. *: <italic>p</italic> &lt; 0.05.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-39184-g007"/>
        </fig>
      </sec>
    </sec>
    <sec id="s3">
      <title>DISCUSSION</title>
      <p>In this study, we identified important characteristics of the PRRT2 protein and its potential functions during neuronal and synaptic development. Using our highly specific antibody, we documented the localization of endogenous Prrt2 at both the pre- and post-synaptic membranes. <italic>PRRT2</italic> mutations could lead to abnormal intracellular trafficking or reduced expression. More significantly, our <italic>in vivo</italic> functional assays using Prrt2 shRNAs showed that a nearly complete Prrt2 knockdown resulted in a delay in neuronal migration during early neural development and also defective spinogenesis. These results pointed to the essential functions of PRRT2 during neural development, which were not recognized before this study but may be critical in the pathomechanisms of <italic>PRRT2</italic>-related disorders.</p>
      <p>Recent studies have revealed that PRRT2 is a component of the AMPAR (Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) complex [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>] and may be involved in neurotransmitter release and glutamate signaling[<xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R32" ref-type="bibr">32</xref>]. Consistently, PRRT2 was found to co-localize with pre- and post-synaptic markers vGlut1 and PSD95 in our study. In addition, our study revealed that PRRT2 co-fractionated with SNAP25 and was localized close to it at synapses, supporting the interactions between these two proteins.</p>
      <p>We observed a reduced protein level in the HEK293T cells expressing the R308C mutant. Reduced expression has been reported in cells expressing other <italic>PRRT2</italic> mutations [<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R33" ref-type="bibr">33</xref>, <xref rid="R34" ref-type="bibr">34</xref>] and could be a common functional loss of PKD-related mutations. It remains unclear whether the decreased protein level in cells was caused by decreased production, protein instability, or both. Either way, this result suggested that haploinsufficiency resulting from some forms of <italic>PRRT2</italic> mutations may be the pathomechanism of PKD-related disorders. Another loss-of-function effect underlying PKD and related diseases was seen in the truncated forms of Prrt2, which were retained in the cytoplasm with some entering the nucleus.</p>
      <p>Using <italic>in utero</italic> electroporation, we found that a further decrease in PRRT2 expression in cortical neurons resulted in delayed neuronal migration in the early stage of development. Furthermore, nearly complete Prrt2 knockdown caused a reduction in dendritic spine density. Consistent with this result, a recent <italic>in vitro</italic> study also showed a decrease in synapses in cultured hippocampal neurons when Prrt2 was knocked down [<xref rid="R32" ref-type="bibr">32</xref>]. Delayed neuronal migration and abnormal spine density are frequently associated with various cognitive, learning and memory deficits [<xref rid="R28" ref-type="bibr">28</xref>, <xref rid="R34" ref-type="bibr">34</xref>â<xref rid="R36" ref-type="bibr">36</xref>]. Our results indicated that these defects may contribute to the severe encephalopathy caused by the rare homozygous or biallelic <italic>PRRT2</italic> mutations [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R37" ref-type="bibr">37</xref>].</p>
      <p>Together, we proposed the potential mechanism that may underlie various <italic>PRRT2</italic>-related diseases (Figure <xref ref-type="fig" rid="F8">8</xref>). PRRT2 participates in normal synaptic functions through interactions with SNAP25 [<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R32" ref-type="bibr">32</xref>] and probably other molecules of the AMPAR complex [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>]. <italic>PRRT2</italic> mutations cause reduced expression and/or intracellular mislocalization of PRRT2 proteins, leading to their functional loss. PRRT2 loss-of-function can also lead to a delay in neuronal migration and synaptic loss. The diverse pathological impacts of <italic>PRRT2</italic> mutations in turn contribute to the wide phenotypic spectrum, from PKD by heterozygous mutations to severe congenital encephalopathy by homozygous or biallelic mutations.</p>
      <fig id="F8" orientation="portrait" position="float">
        <label>Figure 8</label>
        <caption>
          <title>Schematic diagram showing effects of PRRT2 mutation on neuronal migration and dendritic spines in cortical neurons</title>
          <p><bold>A.</bold> Radial glia cells (light green) produce postmitotic neurons (dark green). <bold>B.</bold> Postmitotic neurons then migrate along the radial fiber to the CP. <bold>C.</bold> After reaching the cortical plate, the cells extend dendrites and form synaptic connections with other neurons through dendritic spines. Box shows a magnification of the pre- and post-synaptic regions. PRRT2 (pink) is localized at both the pre- and post-synaptic membranes through interactions with SNAP25<sup>18, 25, 44</sup> and the AMPA receptor<sup>25, 33, 34</sup>. (A', B') In neurons carrying PKD-associated <italic>PRRT2</italic> mutations, reduced expression, mislocalization and other potential defects delay the neuronal migration. (C') PRRT2 mutation also decreases the dendritic spine density and causes synaptic dysfunction, possibly through SNAP25 and/or AMPA receptor pathways.</p>
        </caption>
        <graphic xlink:href="oncotarget-07-39184-g008"/>
      </fig>
    </sec>
    <sec sec-type="methods" id="s4">
      <title>MATERIALS AND METHODS</title>
      <sec id="s4_1">
        <title>Antibody production</title>
        <p>The Prrt2 antibody was generated using antigen prepared by Nickel resin purification from a bacterially-expressed peptide comprising the extracellular domain (amino acids 1-268) of Prrt2 protein with a 6X His tag. Prrt2 proteins from adult rat brain lysates were detected using the first bleed of Prrt2 anti-serum obtained from a rabbit, whereas the preimmune serum was drawn from the rabbit before antigen injection as the control.</p>
      </sec>
      <sec id="s4_2">
        <title>Cell culture and transient transfection</title>
        <p>Cultured hippocampal and cortical neurons were isolated from P0 Sprague-Dawley rats and E18 ICR mice, respectively, according to our previous report [<xref rid="R38" ref-type="bibr">38</xref>]. COS-7 (monkey kidney epithelial cells) and HEK293T (human embryonic kidney cells) cell lines were cultured in Dulbecco's Modified Eagle Medium (DMEM, Life Technologies, USA) supplemented with 10% fetal bovine serum. Transfection was carried out using the Lipofectamine 2000 and 3000 lipofection reagents (Life Technologies, USA) and cells were harvested 24-48 hours after transfection.</p>
      </sec>
      <sec id="s4_3">
        <title>Plasmids and antibodies</title>
        <p>The mouse <italic>Prrt2</italic> cDNA construct was purchased from Origene (MG214094; GenBank Accession No.: NM_01102563). The enhanced green fluorescent protein-tagged Prrt2 (EGFP-Prrt2) constructs of the wild-type <italic>Prrt2</italic> and the 7 PKD-associated mutations were generated and cloned into the pEGFP-C1 vector (Clontech, Palo Alto, CA). The human influenza hemagglutinin-tagged Prrt2 (HA-Prrt2) constructs were cloned into the pcDNA3.1 (â) vector (Clontech, Palo Alto, CA). All mutant constructs were fully sequenced to verify the mutated nucleotides.</p>
      </sec>
      <sec id="s4_4">
        <title>Western blot analysis</title>
        <p>EGFP-Prrt2 and HA-Prrt2 constructs with either wild-type or the point mutation, R308C, were transiently transfected into an HEK293 cell line. Total proteins were harvested at 24 hours after transfection. The protein concentrations were determined using a BCA assay (Thermo Fisher Scientific, USA). The results were quantified using ImageJ software (National Institutes of Health, NIH, USA).</p>
      </sec>
      <sec id="s4_5">
        <title>Knock-down constructs</title>
        <p>For RNAi, short hairpin RNA (shRNA) constructs were based on the pLKO.1-puro vector (RNAi core of Academia Sinica, Taiwan) and pGPU6/GFP/Neo vector (Tools, Taiwan). The <italic>Prrt2</italic> target sequences (shPrrt2 #1: 5â²-CATCAACTTAGGCGTGTATAA-3â² and shPrrt2 #2: 5â²-GGCCACAGACCTCAGTTTAAA-3â²) were chosen from a portion of the <italic>Prrt2</italic> coding region, where the sequence was conserved between human and mouse. The empty vector or a scramble (5â²-TTCTCCGAACGTGTCACGT-3â²) sequence (shControl) was used as the control.</p>
      </sec>
      <sec id="s4_6">
        <title>Immunofluorescence</title>
        <p>Cultured mice neurons were fixed in 4% paraformaldehyde/4% sucrose/ phosphate-buffered saline (PBS) solution for 20 minutes at 4Â°C, followed by PBS rinsing and 0.1% Triton X-100 permeabilization at 4Â°C for 15 minutes. Neurons were then incubated at room temperature (RT) for 20 minutes in blocking solution (2% BSA/4% normal goat serum/PBS). The primary antibodies were diluted in blocking solution and added to neurons for incubation at 4Â°C overnight in a humidified chamber, followed by secondary antibody incubation in the dark at RT for 1 hour. Coverslips were mounted in Prolonged Gold Antifade reagent (Life Technologies, USA) and stored at 4Â°C until imaging.</p>
      </sec>
      <sec id="s4_7">
        <title>Image acquisition</title>
        <p>HEK293T cells expressing wild-type or mutated Prrt2 proteins were imaged by a confocal microscope (Zeiss LSM700, Germany) with a 100X Plan-Apochromat NA = 1.4 oil objective. Final composite images were processed by the ImageJ software (NIH, USA).</p>
      </sec>
      <sec id="s4_8">
        <title>Membrane fractionation and post-synaptic density (PSD) purification</title>
        <p>The adult rat brain was dissected out for subcellular fractionation as previously described [<xref rid="R39" ref-type="bibr">39</xref>]. PSD preparation was performed as described previously [<xref rid="R40" ref-type="bibr">40</xref>].</p>
      </sec>
      <sec id="s4_9">
        <title><italic>In utero</italic> electroporation</title>
        <p>Plasmids were transfected using intraventricular injection of embryonic ICR mice <italic>in utero,</italic> followed by electroporation as previously described [<xref rid="R26" ref-type="bibr">26</xref>]. Embryos were then perfused transcardially using cold PBS (pH 7.4) followed by 4% paraformaldehyde in PBS. Brains were collected and further postfixed in 4% paraformaldehyde overnight at 4Â°C. For brain slice preparation, brains were embedded in 4% low-melting-point agarose (Amresco, USA) dissolved in PBS and sectioned using a Vibratome (Leica, Germany) at a thickness of 100 Î¼m.</p>
      </sec>
      <sec id="s4_10">
        <title>Dendritic spine analysis</title>
        <p>Mouse brains electroporated with EGFP were fixed, sectioned and imaged with a confocal or two-photon microscope equipped with a 40X objective lens (Zeiss, Germany) as previously described [<xref rid="R29" ref-type="bibr">29</xref>]. Apical dendrites extending from the layer (L) 2/3 pyramidal neurons expressing GFP were randomly selected and analyzed semi-automatically with a customized Matlab program. All image analysis and quantification was conducted in a double-blind manner.</p>
        <p>Animals were maintained according to protocols approved by the Institutional Animal Care and Use Committee (IACUC) at National Yang-Ming University. All animal studies were conducted in accordance with the United States Public Health Service's Policy on Humane Care and Use of Laboratory Animals.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>YTL is grateful for the funding from the National Health Research Institutes (NHRI-EX105-10507EC) and Taipei Veterans General Hospital (V104B-015 and V105C-166). She also thank for the Clinical Research Core Laboratory of Taipei Veterans General Hospital for providing experimental space and facilities. CYT is grateful to the Development Center for Biotechnology and Academia Sinica for support. BWS is grateful for the funding support from the Ministry of Science and Technology (MOST 103-2314-B-010-049-MY3, MOST 104-2745-B-010-004, MOST 104-2745-B-010-002), Brain Research Center of National Yang-Ming University (104AC-B19) and Taipei Veterans General Hospital (V103C-109, V104E9-006). JWT is grateful to the Ministry of Science and Technology (101-2320-B-010-077-MY2, 103-2911-I-010-504, 103-2628-B-010-002-MY3, 104-2633-H-010-001, and 105-2633-B-009-003), Taiwan National Health Research Institutes (NHRI-EX103-10314NC), and Academia Sinica, Taiwan (AS-104-TP-B09).</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>
          <bold>CONFLICTS OF INTEREST</bold>
        </p>
        <p>All authors declare no conflicts of interest.</p>
      </fn>
      <fn fn-type="con">
        <p>
          <bold>Author contributions</bold>
        </p>
        <p>Dr. Yo-Tsen Liu drafted the manuscript and Figureures, acquired and analyzed the data.</p>
        <p>Ms. Fang-Shin Nian drafted the manuscript and Figureures, acquired and analyzed the data.</p>
        <p>Ms. Wan-Ju Chou acquired and analyzed the data and revised the manuscript.</p>
        <p>Dr. Chin-Yin Tai acquired and analyzed the data and revised the manuscript.</p>
        <p>Dr. Shang-Yeong Kwan acquired and analyzed the data and revised the manuscript.</p>
        <p>Dr. Chien Chen acquired and analyzed the data and revised the manuscript.</p>
        <p>Ms. Pei-Wen Kuo acquired and analyzed the data and revised the manuscript.</p>
        <p>Mr. Po-Hsi Lin acquired and analyzed the data and revised the manuscript.</p>
        <p>Ms. Chin-Yi Chen acquired and analyzed the data and revised the manuscript.</p>
        <p>Mr. Chia-Wei Huang acquired and analyzed the data and revised the manuscript.</p>
        <p>Dr. Yi-Chung Lee acquired and analyzed the data and revised the manuscript.</p>
        <p>Prof. Bing-Wen Soong contributed to design and conceptualized the study, interpreted the data, revised the manuscript and supervised the study.</p>
        <p>Dr. Jin-Wu Tsai contributed to the design and conceptualization of the study, conducted the statistical analysis, interpreted the data, revised the manuscript and supervised the study.</p>
      </fn>
    </fn-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>BFIE</term>
          <def>
            <p>benign familial infantile epilepsy</p>
          </def>
        </def-item>
        <def-item>
          <term>CP</term>
          <def>
            <p>cortical plate</p>
          </def>
        </def-item>
        <def-item>
          <term>DIV</term>
          <def>
            <p>days <italic>in vitro</italic></p>
          </def>
        </def-item>
        <def-item>
          <term>E</term>
          <def>
            <p>embryonic</p>
          </def>
        </def-item>
        <def-item>
          <term>EA</term>
          <def>
            <p>episodic ataxia</p>
          </def>
        </def-item>
        <def-item>
          <term>EGFP</term>
          <def>
            <p>enhanced green fluorescent protein</p>
          </def>
        </def-item>
        <def-item>
          <term>HA</term>
          <def>
            <p>human influenza hemagglutinin</p>
          </def>
        </def-item>
        <def-item>
          <term>HM</term>
          <def>
            <p>hemiplegic migraine</p>
          </def>
        </def-item>
        <def-item>
          <term>ICCA</term>
          <def>
            <p>infantile convulsions and choreoathetosis</p>
          </def>
        </def-item>
        <def-item>
          <term>IZ</term>
          <def>
            <p>intermediate zone</p>
          </def>
        </def-item>
        <def-item>
          <term>PKD</term>
          <def>
            <p>paroxysmal kinesigenic dyskinesia</p>
          </def>
        </def-item>
        <def-item>
          <term>P</term>
          <def>
            <p>postnatal</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>PRRT2</italic>
          </term>
          <def>
            <p>the proline-rich transmembrane protein 2 gene</p>
          </def>
        </def-item>
        <def-item>
          <term>PRRT2</term>
          <def>
            <p>the proline-rich transmembrane protein</p>
          </def>
        </def-item>
        <def-item>
          <term>PSD</term>
          <def>
            <p>postsynaptic density</p>
          </def>
        </def-item>
        <def-item>
          <term>RNAi</term>
          <def>
            <p>RNA interference</p>
          </def>
        </def-item>
        <def-item>
          <term>shRNA</term>
          <def>
            <p>short hairpin RNA</p>
          </def>
        </def-item>
        <def-item>
          <term>SNAP25</term>
          <def>
            <p>the synaptosomal-associated protein, 25kD</p>
          </def>
        </def-item>
        <def-item>
          <term>SVZ</term>
          <def>
            <p>subventricular zone</p>
          </def>
        </def-item>
        <def-item>
          <term>VZ</term>
          <def>
            <p>ventricular zone</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>ZQ</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ni</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>QJ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Murong</surname>
              <given-names>SX</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>ZY</given-names>
            </name>
          </person-group>
          <article-title>Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia</article-title>
          <source>Nature genetics</source>
          <year>2011</year>
          <volume>43</volume>
          <fpage>1252</fpage>
          <lpage>1255</lpage>
          <pub-id pub-id-type="pmid">22101681</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cloarec</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bruneau</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rudolf</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Massacrier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Salmi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bataillard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boulay</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Caraballo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fejerman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Genton</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lesca</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Motte</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Roubertie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sanlaville</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine</article-title>
          <source>Neurology</source>
          <year>2012</year>
          <volume>79</volume>
          <fpage>2097</fpage>
          <lpage>2103</lpage>
          <pub-id pub-id-type="pmid">23077017</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dale</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Gardiner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Antony</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Houlden</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine</article-title>
          <source>Dev Med Child Neurol</source>
          <year>2012</year>
          <volume>54</volume>
          <fpage>958</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="pmid">22845787</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardiner</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Bhatia</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Stamelou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Kurian</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Wali</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Counihan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schapira</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Spacey</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Valente</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Silveira-Moriyama</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Teive</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Raskin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Lees</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine</article-title>
          <source>Neurology</source>
          <year>2012</year>
          <volume>79</volume>
          <fpage>2115</fpage>
          <lpage>2121</lpage>
          <pub-id pub-id-type="pmid">23077024</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Conti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mei</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Battaglia</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lettori</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Losito</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bruccini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tortorella</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guerrini</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine</article-title>
          <source>Neurology</source>
          <year>2012</year>
          <volume>79</volume>
          <issue>21</issue>
          <fpage>2109</fpage>
          <lpage>2114</lpage>
          <pub-id pub-id-type="pmid">23077026</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scheffer</surname>
              <given-names>IE</given-names>
            </name>
            <name>
              <surname>Grinton</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Heron</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Kivity</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Afawi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Iona</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Goldberg-Stern</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kinali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Guerrini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Marini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sadleir</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Berkovic</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Dibbens</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures</article-title>
          <source>Neurology</source>
          <year>2012</year>
          <volume>79</volume>
          <fpage>2104</fpage>
          <lpage>2108</lpage>
          <pub-id pub-id-type="pmid">23077018</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schubert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Paravidino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bebek</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brockmann</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Capovilla</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dalla Bernardina</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fukuyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Jurkat-Rott</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Anttonen</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Kurlemann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lehesjoki</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Lehmann-Horn</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PRRT2 mutations are the major cause of benign familial infantile seizures</article-title>
          <source>Hum Mutat</source>
          <year>2012</year>
          <volume>33</volume>
          <fpage>1439</fpage>
          <lpage>1443</lpage>
          <pub-id pub-id-type="pmid">22623405</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brockmann</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Episodic movement disorders: from phenotype to genotype and back</article-title>
          <source>Curr Neurol Neurosci Rep</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>379</fpage>
          <pub-id pub-id-type="pmid">23963607</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heron</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Dibbens</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy</article-title>
          <source>J Med Genet</source>
          <year>2013</year>
          <volume>50</volume>
          <fpage>133</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="pmid">23343561</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labate</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tarantino</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Palamara</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gagliardi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cavalcanti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ferlazzo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sturniolo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Incorpora</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Annesi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aguglia</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Gambardella</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Mutations in PRRT2 result in familial infantile seizures with heterogeneous phenotypes including febrile convulsions and probable SUDEP</article-title>
          <source>Epilepsy Res</source>
          <year>2013</year>
          <volume>104</volume>
          <fpage>280</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="pmid">23352743</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chou</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Successful control with carbamazepine of family with paroxysmal kinesigenic dyskinesia of PRRT2 mutation</article-title>
          <source>Biomedicine (Taipei)</source>
          <year>2014</year>
          <volume>4</volume>
          <fpage>15</fpage>
          <pub-id pub-id-type="pmid">25520928</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mao</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Shang</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>YM</given-names>
            </name>
          </person-group>
          <article-title>Genotype-phenotype correlation in a cohort of paroxysmal kinesigenic dyskinesia cases</article-title>
          <source>J Neurol Sci</source>
          <year>2014</year>
          <volume>340</volume>
          <fpage>91</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">24661410</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tan</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Methawasin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Teng</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Seah</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Au</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Foo</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>EK</given-names>
            </name>
          </person-group>
          <article-title>Clinico-genetic comparisons of paroxysmal kinesigenic dyskinesia patients with and without PRRT2 mutations</article-title>
          <source>European journal of neurology</source>
          <year>2014</year>
          <volume>21</volume>
          <fpage>674</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="pmid">23551744</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>XJ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>XL</given-names>
            </name>
            <name>
              <surname>Che</surname>
              <given-names>XQ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 110 patients</article-title>
          <source>Neurology</source>
          <year>2015</year>
          <volume>85</volume>
          <fpage>1546</fpage>
          <lpage>1553</lpage>
          <pub-id pub-id-type="pmid">26446061</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delcourt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Riant</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Milh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Roze</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Humbertclaude</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Korff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Des Portes</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Szepetowski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Doummar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Echenne</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Quintin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Leboucq</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Singh Amrathlal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rochette</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Severe phenotypic spectrum of biallelic mutations in PRRT2 gene</article-title>
          <source>Journal of neurology, neurosurgery, and psychiatry</source>
          <year>2015</year>
          <volume>86</volume>
          <fpage>782</fpage>
          <lpage>785</lpage>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meneret</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gaudebout</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Riant</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vidailhet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Depienne</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roze</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>PRRT2 mutations and paroxysmal disorders</article-title>
          <source>European journal of neurology</source>
          <year>2013</year>
          <volume>20</volume>
          <fpage>872</fpage>
          <lpage>878</lpage>
          <pub-id pub-id-type="pmid">23398397</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Soong</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e38543</fpage>
          <pub-id pub-id-type="pmid">22870186</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stelzl</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Worm</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lalowski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haenig</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brembeck</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Goehler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stroedicke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zenkner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schoenherr</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koeppen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Timm</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mintzlaff</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bock</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kietzmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goedde</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A human protein-protein interaction network: a resource for annotating the proteome</article-title>
          <source>Cell</source>
          <year>2005</year>
          <volume>122</volume>
          <fpage>957</fpage>
          <lpage>968</lpage>
          <pub-id pub-id-type="pmid">16169070</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bruneau</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Roll</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Roberson</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Hermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ashizawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Baykan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bhatia</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bressman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bruno</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Brunt</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Caraballo</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions</article-title>
          <source>Cell Rep</source>
          <year>2012</year>
          <volume>1</volume>
          <fpage>2</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">22832103</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling</article-title>
          <source>Int J Mol Sci</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>9134</fpage>
          <lpage>9151</lpage>
          <pub-id pub-id-type="pmid">25915028</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christensen</surname>
              <given-names>BN</given-names>
            </name>
          </person-group>
          <article-title>Distribution of electrotonic synapses on identified lamprey neurons: a comparison of a model prediction with an electron microscopic analysis</article-title>
          <source>J Neurophysiol</source>
          <year>1983</year>
          <volume>49</volume>
          <fpage>705</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="pmid">6834095</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christensen</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Teubl</surname>
              <given-names>WP</given-names>
            </name>
          </person-group>
          <article-title>Localization of synaptic input on dendrites of a lamprey spinal cord neurone from physiological measurements of membrane properties</article-title>
          <source>J Physiol</source>
          <year>1979</year>
          <volume>297</volume>
          <fpage>319</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="pmid">536916</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakatsuji</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Efficient gene transfer into the embryonic mouse brain using in vivo electroporation</article-title>
          <source>Developmental biology</source>
          <year>2001</year>
          <volume>240</volume>
          <fpage>237</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="pmid">11784059</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tabata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakajima</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex</article-title>
          <source>Neuroscience</source>
          <year>2001</year>
          <volume>103</volume>
          <fpage>865</fpage>
          <lpage>872</lpage>
          <pub-id pub-id-type="pmid">11301197</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noctor</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Flint</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Dammerman</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Kriegstein</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Neurons derived from radial glial cells establish radial units in neocortex</article-title>
          <source>Nature</source>
          <year>2001</year>
          <volume>409</volume>
          <fpage>714</fpage>
          <lpage>720</lpage>
          <pub-id pub-id-type="pmid">11217860</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Bremner</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Vallee</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Dual subcellular roles for LIS1 and dynein in radial neuronal migration in live brain tissue</article-title>
          <source>Nature neuroscience</source>
          <year>2007</year>
          <volume>10</volume>
          <fpage>970</fpage>
          <lpage>979</lpage>
          <pub-id pub-id-type="pmid">17618279</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kriegstein</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Vallee</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>LIS1 RNA interference blocks neural stem cell division, morphogenesis, and motility at multiple stages</article-title>
          <source>The Journal of cell biology</source>
          <year>2005</year>
          <volume>170</volume>
          <fpage>935</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="pmid">16144905</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kasai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsuzaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yasumatsu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakahara</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Structure-stability-function relationships of dendritic spines</article-title>
          <source>Trends Neurosci</source>
          <year>2003</year>
          <volume>26</volume>
          <fpage>360</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">12850432</pub-id>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Qiao</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gan</surname>
              <given-names>WB</given-names>
            </name>
          </person-group>
          <article-title>Experience-dependent plasticity of dendritic spines of layer 2/3 pyramidal neurons in the mouse cortex</article-title>
          <source>Dev Neurobiol</source>
          <year>2016</year>
          <volume>76</volume>
          <fpage>277</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">26033635</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwenk</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Harmel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Brechet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zolles</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Berkefeld</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Bildl</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Baehrens</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kulik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klocker</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Schulte</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Fakler</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes</article-title>
          <source>Neuron</source>
          <year>2012</year>
          <volume>74</volume>
          <fpage>621</fpage>
          <lpage>633</lpage>
          <pub-id pub-id-type="pmid">22632720</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shanks</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Savas</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Maruo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cais</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Hirao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Noda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Greger</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Yates</surname>
              <given-names>JR</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Differences in AMPA and kainate receptor interactomes facilitate identification of AMPA receptor auxiliary subunit GSG1L</article-title>
          <source>Cell Rep</source>
          <year>2012</year>
          <volume>1</volume>
          <fpage>590</fpage>
          <lpage>598</lpage>
          <pub-id pub-id-type="pmid">22813734</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valente</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Castroflorio</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fadda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sterlini</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cervigni</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Prestigio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Giovedi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Onofri</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mura</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guarnieri</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Marte</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Orlando</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zara</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fassio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Valtorta</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PRRT2 Is a Key Component of the Ca-Dependent Neurotransmitter Release Machinery</article-title>
          <source>Cell Rep</source>
          <year>2016</year>
          <volume>15</volume>
          <fpage>117</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">27052163</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardiner</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Jaffer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Labrum</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Erro</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Xiromerisiou</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stamelou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kullmann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jarman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kurian</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bhatia</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Houlden</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The clinical and genetic heterogeneity of paroxysmal dyskinesias</article-title>
          <source>Brain</source>
          <year>2015</year>
          <volume>138</volume>
          <fpage>3567</fpage>
          <lpage>3580</lpage>
          <pub-id pub-id-type="pmid">26598494</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ji</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Novel loss-of-function PRRT2 mutation causes paroxysmal kinesigenic dyskinesia in a Han Chinese family</article-title>
          <source>BMC Neurol</source>
          <year>2014</year>
          <volume>14</volume>
          <fpage>146</fpage>
          <pub-id pub-id-type="pmid">25027704</pub-id>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Penzes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cahill</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>VanLeeuwen</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Woolfrey</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Dendritic spine pathology in neuropsychiatric disorders</article-title>
          <source>Nature neuroscience</source>
          <year>2011</year>
          <volume>14</volume>
          <fpage>285</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">21346746</pub-id>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ash</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Suter</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rudy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Torsky</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Zoghbi</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Smirnakis</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome</article-title>
          <source>The Journal of neuroscience</source>
          <year>2013</year>
          <volume>33</volume>
          <fpage>19518</fpage>
          <lpage>19533</lpage>
          <pub-id pub-id-type="pmid">24336718</pub-id>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Najmabadi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Garshasbi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zemojtel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Abedini</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Hosseini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Behjati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jamali</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zecha</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mohseni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Puttmann</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vahid</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moheb</surname>
              <given-names>LA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deep sequencing reveals 50 novel genes for recessive cognitive disorders</article-title>
          <source>Nature</source>
          <year>2011</year>
          <volume>478</volume>
          <fpage>57</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">21937992</pub-id>
        </element-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tai</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Mysore</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schuman</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Activity-regulated N-cadherin endocytosis</article-title>
          <source>Neuron</source>
          <year>2007</year>
          <volume>54</volume>
          <fpage>771</fpage>
          <lpage>785</lpage>
          <pub-id pub-id-type="pmid">17553425</pub-id>
        </element-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niethammer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Ayala</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Morabito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein</article-title>
          <source>Neuron</source>
          <year>2000</year>
          <volume>28</volume>
          <fpage>697</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="pmid">11163260</pub-id>
        </element-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>KO</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein</article-title>
          <source>Neuron</source>
          <year>1992</year>
          <volume>9</volume>
          <fpage>929</fpage>
          <lpage>942</lpage>
          <pub-id pub-id-type="pmid">1419001</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>